VP44.02: Risk of fetal loss following amniocentesis or chorionic villous sampling in twin pregnancies: a systematic review and meta‐analysis

Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.

OBJECTIVES To estimate procedure-related risks of miscarriage following amniocentesis and chorionic villus sampling (CVS) based on a systematic review of the literature and a meta-analysis. METHODS A search of MEDLINE, EMBASE, CINHAL and The Cochrane Library (2000-2014) was performed to review relevant citations reporting procedure-related complications of amniocentesis and CVS. Only studies ...

Amniocentesis and Chorionic Villus Sampling

Comparison of Complications of Chorionic Villus Sampling and Amniocentesis

Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study.

OBJECTIVE To assess the fetal loss rate following amniocentesis and chorionic villus sampling (CVS). METHODS This was a national registry-based cohort study, including all singleton pregnant women who had an amniocentesis (n = 32 852) or CVS (n = 31 355) in Denmark between 1996 and 2006. Personal registration numbers of women having had an amniocentesis or a CVS were retrieved from the Danish...

Pregnancy Loss Following Amniocentesis or CVS Sampling—Time for a Reassessment of Risk

Risk of procedure-related pregnancy loss is currently widely quoted in the UK as 1% for amniocentesis and 1.5% for chorionic villus sampling. Published data suggest that these risk figures are out of date and inaccurate, and that new guidelines are required for pre-test counseling. It is our opinion that accurate and evidence-based information concerning miscarriage risk is vital when counselin...